Skip to main content Back to Top
Advertisement

1/5/2023

Famotidine Injection

Products Affected - Description

    • Famotidine solution for injection, Athenex, 10 mg/mL, 2 mL vial, 25 count, NDC 70860-0751-02
    • Famotidine solution for injection, Baxter, 20 mg, 50 mL premixed bag, 12 count, NDC 00338-5197-41
    • Famotidine solution for injection, Hikma, 10 mg/mL, 2 mL vial, 25 count, NDC 00641-6022-25
    • Famotidine solution for injection, Hikma, 10 mg/mL, 20 mL vial, 10 count, NDC 00641-6021-10
    • Famotidine solution for injection, Hikma, 10 mg/mL, 4 mL vial, 25 count, NDC 00641-6023-25
    • Famotidine solution for injection, Mylan Institutional (Viatris), 10 mg/mL, 2 mL vial, 25 count, NDC 67457-0433-22

Reason for the Shortage

    • Athenex has famotidine injection available.
    • Baxter has famotidine injection on shortage due to increased demand.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage.
    • Viatris did not provide a reason for the shortage.

Available Products

    • Famotidine solution for injection, Fresenius Kabi, 10 mg/mL, 2 mL vial, 25 count, NDC 63323-0739-12
    • Famotidine solution for injection, Fresenius Kabi, 10 mg/mL, 20 mL vial, 10 count, NDC 63323-0738-20
    • Famotidine solution for injection, Fresenius Kabi, 10 mg/mL, 4 mL vial, 10 count, NDC 63323-0738-09
    • Famotidine solution for injection, Mylan Institutional (Viatris), 10 mg/mL, 20 mL vial, 10 count, NDC 67457-0457-20
    • Famotidine solution for injection, Mylan Institutional (Viatris), 10 mg/mL, 4 mL vial, 10 count, NDC 67457-0448-43

Estimated Resupply Dates

    • Athenex has famotidine 10 mg/mL 2 mL vials on back order and the company estimates a release date of January 2023.
    • Baxter has famotidine 20 mg/50 mL premixed bags on back order and the company estimates a release date of early-January 2023.
    • Hikma has famotidine 10 mg/mL 2 mL vials on allocation. The 4 mL and 20 mL vials are on back order and the company estimates a release date of late-January to early-February 2023.
    • Viatris has famotidine 10 mg/mL 2 mL vials on back order and the company estimates a release date of mid-January 2023.

Updated

Updated January 5, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 30, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.